Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Alpine Immune Sciences (NASDAQ:ALPN) With a Buy

ME Staff
-
0

Analyst Ratings For Alpine Immune Sciences (NASDAQ:ALPN)

Today, Ladenburg Thalmann Financial Services initiated coverage on Alpine Immune Sciences (NASDAQ:ALPN) with a Buy.

There are 1 buy rating on the stock.

The current consensus rating on Alpine Immune Sciences (NASDAQ:ALPN) is Buy (Score: 3.00) with a consensus target price of per share, a potential .

Some recent analyst ratings include

  • 7/27/2017-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.


    Recent Trading Activity for Alpine Immune Sciences (NASDAQ:ALPN)
    Shares of Alpine Immune Sciences closed the previous trading session at 8.78 down -0.77 -8.06% with 28,876 shares trading hands.